TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 33 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,861 | -38.8% | 21,691 | 0.0% | 0.00% | – |
| Q2 2023 | $6,312 | -84.6% | 21,691 | 0.0% | 0.00% | – |
| Q1 2023 | $40,996 | +58.7% | 21,691 | +25.1% | 0.00% | – |
| Q4 2022 | $25,832 | -10.9% | 17,337 | 0.0% | 0.00% | – |
| Q3 2022 | $29,000 | -17.1% | 17,337 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -23.9% | 17,337 | 0.0% | 0.00% | – |
| Q1 2022 | $46,000 | -4.2% | 17,337 | 0.0% | 0.00% | – |
| Q4 2021 | $48,000 | -28.4% | 17,337 | 0.0% | 0.00% | – |
| Q3 2021 | $67,000 | -40.7% | 17,337 | 0.0% | 0.00% | – |
| Q2 2021 | $113,000 | – | 17,337 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $848,082 | 0.28% |
| Ikarian Capital, LLC | 2,765,530 | $492,265 | 0.06% |
| JOHNSON & JOHNSON | 84,003 | $14,953 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $46,074 | 0.00% |
| BlackRock Inc. | 267,821 | $47,673 | 0.00% |
| Bank of New York Mellon Corp | 10,259 | $1,826 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,835 | $2,819 | 0.00% |
| Truvestments Capital LLC | 318 | $57 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,407 | $1,852 | 0.00% |
| Cutler Group LLC / CA | 1,200 | $0 | 0.00% |